Cargando…
Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
BACKGROUND AND AIMS: In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario. METHODS: PubMed and Google Scholar search engines were searched using the key terms ‘telem...
Autores principales: | Ghosh, Amerta, Gupta, Ritesh, Misra, Anoop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of Diabetes India.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129346/ https://www.ncbi.nlm.nih.gov/pubmed/32283497 http://dx.doi.org/10.1016/j.dsx.2020.04.001 |
Ejemplares similares
-
Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic
por: Ghosh, Amerta, et al.
Publicado: (2020) -
Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India
por: Ghosh, Amerta, et al.
Publicado: (2020) -
Letter to the editor in response to: Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
por: Vaishya, Raju, et al.
Publicado: (2020) -
Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: A proposed classification
por: Misra, Anoop, et al.
Publicado: (2021) -
Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis
por: Ghosal, Samit, et al.
Publicado: (2020)